Dec+Flu+Bu Conditioning Regimen for Elderly AML in CR Undergoing Allo-HSCT
Status:
Recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is reported to be able to
improve the outcomes for elderly acute myeloid leukemia (AML) in complete remission (CR). At
present, the best conditioning regimen for elderly AML in CR remains in discussion. In this
prospective study, the safety and efficacy of Dec+Flu+Bu myeloablative conditioning regimens
in patients with elderly AML in CR undergoing allo-HSCT are evaluated.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Nanfang Hospital of Southern Medical University
Collaborators:
Guangzhou First People's Hospital Peking University People's Hospital Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Third Affiliated Hospital, Sun Yat-Sen University Zhujiang Hospital